Growth Metrics

OptimizeRx (OPRX) Accumulated Depreciation & Amortization: 2010-2024

Historic Accumulated Depreciation & Amortization for OptimizeRx (OPRX) over the last 13 years, with Q4 2024 value amounting to $258000.0.

  • OptimizeRx's Accumulated Depreciation & Amortization rose 7086.09% to $258000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $258000.0, marking a year-over-year increase of 7086.09%. This contributed to the annual value of $258000.0 for FY2024, which is 7086.09% up from last year.
  • Per OptimizeRx's latest filing, its Accumulated Depreciation & Amortization stood at $258000.0 for Q4 2024, which was up 7086.09% from $151000.0 recorded in Q4 2023.
  • In the past 5 years, OptimizeRx's Accumulated Depreciation & Amortization ranged from a high of $324349.0 in Q4 2021 and a low of $151000.0 during Q4 2023
  • Its 4-year average for Accumulated Depreciation & Amortization is $238101.8, with a median of $238529.0 in 2020.
  • In the last 5 years, OptimizeRx's Accumulated Depreciation & Amortization skyrocketed by 4710.17% in 2020 and then skyrocketed by 7086.09% in 2024.
  • Over the past 4 years, OptimizeRx's Accumulated Depreciation & Amortization (Quarter) stood at $219058.0 in 2020, then surged by 48.07% to $324349.0 in 2021, then plummeted by 53.45% to $151000.0 in 2023, then soared by 70.86% to $258000.0 in 2024.
  • Its Accumulated Depreciation & Amortization stands at $258000.0 for Q4 2024, versus $151000.0 for Q4 2023 and $324349.0 for Q4 2021.